Corinne de Vries heads the Office for Science and Innovation Support in the Human Medicines Research & Development Support Division at the European Medicines Agency. In this office, Corinne coordinates the involvement of EMA with externally funded regulatory science projects such as those funded under Horizon 2020 and Horizon Europe. In this role, she is on the Scientific Committee of the Innovative Medicines Initiative (a public-private partnership funding scheme of Horizon 2020). EMA is keen to bridge the gap between academia and regulators to help enhance successful development of innovative medicines and have developed a number of initiatives to help achieve this.
Before making the move to the regulatory environment, Corinne worked in academia for 20 years where she led on pharmacoepidemiology research, including drug safety in pregnancy studies.